Evaluation of Sentinel Node Biopsy in Locally Advanced Breast Cancer Patients Who Become Clinically Node-Negative after Neoadjuvant Chemotherapy: A Preliminary Study. (12th October 2011)
- Record Type:
- Journal Article
- Title:
- Evaluation of Sentinel Node Biopsy in Locally Advanced Breast Cancer Patients Who Become Clinically Node-Negative after Neoadjuvant Chemotherapy: A Preliminary Study. (12th October 2011)
- Main Title:
- Evaluation of Sentinel Node Biopsy in Locally Advanced Breast Cancer Patients Who Become Clinically Node-Negative after Neoadjuvant Chemotherapy: A Preliminary Study
- Authors:
- Thomas, Shaji
Prakash, Apurva
Goyal, Vinay
Popli, Manju Bala
Agarwal, Shilpi
Choudhury, Monisha - Other Names:
- Cavalli Luciane R. Academic Editor.
- Abstract:
- Abstract : Introduction . Controversy continues over the appropriate timing of sentinel lymph node (SLN) biopsy in locally advanced breast cancer (LABC) patients receiving neoadjuvant chemotherapy. We evaluated the feasibility and accuracy of SLN biopsy in LABC patients with cytology-proven axillary nodal metastasis who become clinically node-negative after neoadjuvant chemotherapy. Materials . 30 consecutive patients with LABC, who had become clinically node-negative after 3 cycles of neoadjuvant chemotherapy, were included in the study. They were then subjected to SLN biopsy, axillary lymph node dissection, and breast surgery. Results . Sentinel nodes were successfully identified in 26 of the 30 patients, resulting in an identification rate of 86.67%, sensitivity of 83.33%, false negative rate of 20%, negative predictive value of 72.73%, and an overall accuracy of 88.46%. No complications were observed as a result of dye injection. Conclusions . SLN biopsy is feasible and safe in LABC patients with cytology-positive nodes who become clinically node-negative after neoadjuvant chemotherapy. Our accuracy rate, identification rate, and false negative rate are comparable to those in node-negative LABC patients. SLN biopsy as a therapeutic option in LABC after neoadjuvant chemotherapy is a promising option which should be further investigated.
- Is Part Of:
- International journal of breast cancer. Volume 2011(2011)
- Journal:
- International journal of breast cancer
- Issue:
- Volume 2011(2011)
- Issue Display:
- Volume 2011, Issue 2011 (2011)
- Year:
- 2011
- Volume:
- 2011
- Issue:
- 2011
- Issue Sort Value:
- 2011-2011-2011-0000
- Page Start:
- Page End:
- Publication Date:
- 2011-10-12
- Subjects:
- Breast -- Cancer -- Periodicals
Periodicals
Breast Neoplasms
Breast -- Cancer
Periodicals
Periodicals
616.99449 - Journal URLs:
- https://www.hindawi.com/journals/ijbc/ ↗
http://bibpurl.oclc.org/web/45884 ↗
http://www.ncbi.nlm.nih.gov/pmc/journals/1706/ ↗ - DOI:
- 10.4061/2011/870263 ↗
- Languages:
- English
- ISSNs:
- 2090-3170
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD Digital store
- Ingest File:
- 10722.xml